StemCells Inc (STEM.O)

STEM.O on Consolidated Issue listed on NASDAQ Capital Market

1.22USD
30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$1.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
664,043
52-wk High
$2.43
52-wk Low
$1.02

STEM.O

Chart for STEM.O

About

StemCells, Inc. (StemCells) is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related... (more)

Overall

Beta: 1.56
Market Cap (Mil.): $83.74
Shares Outstanding (Mil.): 68.64
Dividend: --
Yield (%): --

Financials

  STEM.O Industry Sector
P/E (TTM): -- 170.49 34.41
EPS (TTM): -0.66 -- --
ROI: -146.41 -1.91 17.37
ROE: -1,090.59 -7.10 18.18
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF89.30 +1.60
Pfizer Inc. (PFE.N) $29.84 +0.35
Roche Holding Ltd. (ROG.VX) CHF285.90 +2.50
Merck & Co., Inc. (MRK.N) $57.31 +1.11
Sanofi SA (SASY.PA) €74.12 +2.21
Abbott Laboratories (ABT.N) $43.49 +0.75
Amgen, Inc. (AMGN.OQ) $161.58 --
Merck KGaA (MRCG.DE) €63.00 -1.90
Biogen Idec Inc (BIIB.OQ) $321.00 --
Shire PLC (SHP.L) 4,194.67p +28.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks